NOV 23, 2019 11:20 PM PST

Can artificial intelligence increase tuberculosis drug development?

WRITTEN BY: Nouran Amin

It’s no secret that there is a shortage of tuberculosis drug development. To combat this issue, researchers at the University of Michigan designed a predicative software tool for drug candidates that can serve as an effective treatment. The tool is referred to as ‘INDIGO’ short for INferring Drug Interactions using chemoGenomics and Orthology.

Tuberculosis is the world’s most fatal bacterial infection killing roughly 1.8 million people annually.

Learn more about tuberculosis, the world’s deadliest bacterial infection:

“This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive,” said Sriram Chandrasekaran, U-M assistant professor of biomedical engineering, who leads the research.

INDIGO has shown that tuberculosis drugs (Bedaquiline, Clofazimine, Rifampicin, Clarithromycin) can be potent when paired with antipsychotics like ‘thioridazine’ or antimalarials drugs, for example ‘P218’.

The findings of the study were published in mBio.

“This tool can accurately predict the activity of drug combinations, including synergy—where the activity of the combination is greater than the sum of the individual drugs,” said Shuyi Ma, a research scientist at the University of Washington and a first author of the study. “It also accurately predicts antagonism between drugs, where the activity of the combination is lesser. In addition, it also identifies the genes that control these drug responses.”

“Successful combinations identified by INDIGO, when tested in a lab setting, showed synergy 88.8% of the time,” Chandrasekaran said.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 21, 2020
Genetics & Genomics
JAN 21, 2020
Can CRISPR Replace Antibiotics?
Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019...
JAN 21, 2020
Technology
JAN 21, 2020
Novel Printer Creates Realistic Holograms
A novel printer was recently developed to produce digital 3D holograms with realistic color. The printer could hold valuable applications in the recreation...
JAN 21, 2020
Chemistry & Physics
JAN 21, 2020
Electrifying Breakthrough: New Tech Adds 200 Miles to EVs with only 10-Min Charging
One of the most noticeable drawbacks of electric vehicles (EVs) is their long charging time. That's why the U.S. Department of Energy has set a goal to...
JAN 21, 2020
Technology
JAN 21, 2020
An app that can help better monitor Parkinson's Disease
A study published in the Journal of Parkinson's Disease describes how an app, called ‘SleepFit’, could be used as a useful tool in monitori...
JAN 21, 2020
Technology
JAN 21, 2020
How to design robots with flexible bodies?
Scientists at MIT develop an efficient way to optimize and control the design of soft robots in order to complete complex tasks. "Soft robots are infi...
JAN 21, 2020
Clinical & Molecular DX
JAN 21, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramou...
Loading Comments...